After a mild flu season in 2020-21, health officials are voicing their concern that the upcoming flu season could be significantly worse. This, combined with Covid-19, could cause a 'Twindemic', and immunosuppressed infusion patients are most at risk.
The immunosuppressed have disproportionately high hospitalization rates for acute respiratory illnesses, shed influenza viruses for longer periods, and frequently need mechanical ventilation. Immunosuppression also increases the risks and severity of primary or reactivation infections.
Immunosuppressed infusion patients should receive their flu vaccine by November 1st to achieve optimal immunogenicity.
For more on how we can help your infusion patients this flu season, please click here.